2023, Número 3
<< Anterior Siguiente >>
Arch Neurocien 2023; 28 (3)
Case report: 29-year-old male with hemichorea-hemiballismus as the initial manifestation of cerebral toxoplasmosis in the setting of untreated HIV
Violante-Villanueva A, López-Hernández JC, Salas-Alvarado L, García X
Idioma: Ingles.
Referencias bibliográficas: 14
Paginas: 40-43
Archivo PDF: 216.23 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associatedopportunistic CNS infections: pathophysiology, diagnosis andtreatment. Nat Rev Neurol. 2016;12(11):662-74. doi: 10.1038/nrneurol.2016.149
Patel AR, Patel AR, Desai S. Acute hemiballismus as the presentingfeature of parietal lobe infarction. Cureus. 2019;11(5):e4675.doi: 10.7759/cureus.4675
Dimal NPM, Santos NJC, Reyes NGD, Astejada MN, JamoraRDG. Hemichorea-hemiballismus as a presentation of cerebritisfrom intracranial toxoplasmosis and tuberculosis. Tremor OtherHyperkinet Mov. 2021;11:2. doi: 10.5334/tohm.576
Mattos JP, de Rosso AL, Corrêa RB, Novis S. Hemicoreaasociada a toxoplasmosis cerebral y SIDA. Arq Neuropsiquiatr.1995;53(3A):534.
Postuma RB, Lang AE. Hemiballism: revisiting a classicdisorder. Lancet Neurol. 2003;2:661-8. doi: 10.1016/s1474-4422(03)00554-4
Navia BA, Petito CK, Gold JWM, Cho E ‐S, Jordan BD, PriceRW. Cerebral toxoplasmosis complicating the acquired immunedeficiency syndrome: Clinical and neuropathological findings in27 patients. Ann Neurol. 1986;19(3):224-38.
Kim JS. Case report: vesicocutaneous fistula. Can Fam Physician.2001;47(10):788-9.
Tse W, Cersosimo MG, Gracies JM, Morgello S, OlanowCW, Koller W. Movement disorders and AIDS: a review.Park Relat Disord. 2004;10(6):323-34. doi: 10.1016/j.parkreldis.2004.03.001
Marcus C, Feizi P, Hogg J, Summerfield H, Castellani R, SriwastavaS, et al. Imaging in differentiating cerebral toxoplasmosisand primary CNS lymphoma with special focus on FDG PET/CT. Am J Roentgenol. 2021;216(1):157-64. doi: 10.2214/AJR.19.22629
Safarpour H, Cevik M, Zarean M, Barac A, Hatam-NahavandiK, Rahimi MT, et al. Global status of Toxoplasma gondii infectionand associated risk factors in people living with HIV. Aids.2020;34(3):469-74. doi: 10.1097/QAD.0000000000002424
Schlüter D, Barragan A. Advances and challenges in understandingcerebral toxoplasmosis. Front Immunol. 2019;10:242. doi:10.3389/fimmu.2019.00242
Vidal JE. HIV-related cerebral toxoplasmosis revisited: currentconcepts and controversies of an old disease. J Int AssocProvid AIDS Care. 2019;18:2325958219867315. doi:10.1177/2325958219867315
Hernandez AV, Thota P, Pellegrino D, Pasupuleti V, Benites-ZapataVA, Deshpande A, et al. A systematic review and meta-analysisof the relative efficacy and safety of treatment regimens forHIV-associated cerebral toxoplasmosis: is trimethoprimsulfamethoxazolea real option? HIV Med. 2017;18(2):115-24.doi: 10.1111/hiv.12402
Hosoda T, Mikita K, Ito M, Nagasaki H, Sakamoto M. Cerebraltoxoplasmosis with multiple hemorrhage lesions in an HIVinfected patient: A case report and literature review. Parasitol Int.2021;81:102280. doi: 10.1016/j.parint.2020.102280
Texto completo
Cómo citar este artículo